Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Non-GAAP other income adjustments by Quarter
Non-GAAP other income (expense) adjustments (equity securities fair value, $M) ($M)
Gilead Sciences Non-GAAP other income adjustments: -$343M in Q2 2026, up 141.5% from a year earlier.
Where the Q2 2026 figure comes from
“|| Other (income) expense, net, adjustments | (343) | (142) | (485) | 284”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-08-04) ↗
Reported in Form 8-K GAAP to Non-GAAP Reconciliation.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Gilead Sciences Non-GAAP other income adjustments ($M), quarterly Q3 2017–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-adj-other-inc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.